No Detail Found!

Role of T2 Textural Analysis of Prostate Lesion: A Retrospective Study

Author(s)
ALALI MESHARI ALI A Majmaah University,Al Majmaah,Saudi Arabia
Abstract
Prostate cancer is diagnosed in two-thirds of instances in the world's more developed regions. Prostate cancer was detected in 180,890 new cases in the United States in 2016, according to the American Cancer Society. One out of every six men is projected to develop prostate cancer at some point in their lives. The study's major purpose was to develop a textural analysis-based classifier to differentiate between benign and malignant prostate tumors using MRI-T2WI. Materials and method: The retrospective study was conducted in the department of radiology in KKUH. Total 93 lesions from prostate cases were performed in KKUH from 2015 to 2017. About 75 lesions of 48 patients were included in this study. Eleven haralick features from region of intrests (ROIs) were extracted. After matching them with traces done by consultants in Profuse software, which was utilized for image-guided biopsy, digital rectal examination (DRE), prior biopsy (Prior bx) lesions were traced using ImageJ (MRI-ultrasound fusion). Weka software used this to create a classifier that distinguishes between malignant and benign tumors. Result: The age of total 48 patients was in the interquartile range of 59.0-70.0, with an average of 64.4 years. The PSA was observed an average of 22.5 with an SD of 50.5 and an interquartile of 10.0. The mean size of the prostrate was 3.2 cm with SD 1.9. Among 48 patients Digital rectal examination (DRE) 8 (16.7%) and 40 (83.3%), Prior biopsy (PRIOR BX) 2 (4.2%) and 46 (95.8%), PI-RADS 22 (45.8%) and 26 (54.2%) were observed positive and negative respectively. In DRE, 88% sensitivity 55% specificity with PSA 9.75 (p-value 0.008) were observed. 100% of sensitivity, 41% specificity with PSA 8.19 (p-value 0.897) were found in PRIOR BX, but in MRI, 55% of sensitivity 69% specificity with PSA 10.70 (p-value 0.107) were observed. Conclusion: T2 texture analysis is good in classifying prostate lesions with acceptable sensitivity and specificity. T2W MRIbased textural analysis agreed with pathological findings from many institutions and was sensitive to underlying pathological differences between low- and intermediate/high-grade prostate cancers. Actors in the diagnostic performance, such as DWI/ADC and perfusion, histogram parameters, and other features with distinct orientations and lengths, could help doctors discriminate benign and malignant prostate nodules, allowing for more efficient and precise clinical decisions.
Publication Details
Page(s) 1086-1089
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 03, Year: 2022

Request the full text from PASTIC

Keywords
MRI, cancer, Textural analysis, Prostrate lesion
References
Torre LA,Bray F,Siegel RL,Anunobi CC,Akinde OR,Elesha SO,Daramola AO,Tijani KH,Ojewola RW .2011 .Prostate diseases in Lagos, Nigeria: a histologic study with tPSA correlation. Nigerian Postgrad Med J, 18(2) : 98-104.
Cancer Society American .2016 .Key statistics for prostate cancer. , : .
Siegel R,Naishadham D,Jemal A .2013 .. CA Cancer J Clin, 63(1) : 11-30.
Barakzai Muhammed Abrar,Iqbal MM,KJ MM .2011 .Histopathological lesions in transrectal ultrasound-guided biopsies of prostate in patients with raised serum prostate-specific antigen: a preliminary report. J Nephro-Urology Monthly, 3(3) : 186-190.
Davnall F,Yip CS,Ljungqvist G,Selmi M,Ng F,Sanghera B,Ganeshan B,Miles KA,Ploussard G,Epstein JI,Montironi R,Carroll PR,Wirth M,Grimm MO .2011 .The contemporary concept of significant versus insignificant prostate cancer. Eur Urol, 60(2) : 291-303.
Mottet N,Bellmunt J,Briers E,van den Bergh RCN,Bolla M,van Casteren NJ .2015 .. Guidelines on Prostate Cancer, : .
Guidelines-ProstateCancer- .2015 .. -v2.pdf. Accessed 1 Dec, : .
Barentsz JO,Richenberg J,Clements R,Choyke P,Verma S,Villeirs G . .ESUR prostate MR guidelines 2012. , : .
Weinreb JC,Barentsz JO,Choyke PL,Cornud F,Haider MA,Macura KJ,Urol Eur .2016 .PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 69(1) : 16-40.
Barentsz JO,Weinreb JC,Verma S,Thoeny HC,Tempany CM,Shtern F .2016 .Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol, 69(1) : 41-9.
Lubner MG,Smith AD,Sandrasegaran K,Sahani DV,Pickhardt PJ,Schieda N,Lim CS,Zabihollahy F .2021 .Quantitative prostate MRI. J Magn Reson Imaging, 53 : 1645-1503.
Lovinfosse P,Polus M,Van Daele D .2018 .FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. Eur J Nucl Med Mol Imaging, 45 : 375.
Egevad L,Delahunt B,Srigley JR,Samaratunga H. International . .Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading. APMIS., : .
.2016 .-weighted MRI-derived textural features refect prostate cancer aggressiveness: preliminary results. Eur. Radiol., 124 : 433-5.
.2016 .. , : 1.
Vignati A. .2015 .Texture features on T2-weighted magnetic resonance imaging: new potential biomarkers for prostate cancer aggressiveness. Phys. Med. Biol, 60 : 2685-2701.
Thompson L.C.,Pokorny M.R. Multiparametric .2015 .MRI in the diagnosis of prostate cancer-A generational change. Aust. Fam. Physician, 44 : 597-602.
Fütterer J.J.,S.W. J.J.,T.W. J.J.,J. J.J.,H.J. J.J.,Hulsbergen-Van de Kaa P.,Witjes C.A.,Krabbe J.A.,Heerschap P.F.,A. P.F.,Tanimoto A.,Nakashima J.,H. J.,H. J.,S. J.,Pinto B.,Mani P.A.,H. P.A.,Pang M.,McKinney Y.,Khurana Y.L.,Ravizzini K.,Albert G.C.,P.S. G.C.,M.J. G.C. .2007 .Prostate cancer screening: The clinical value of diffusionweighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J. Magn. Reson. Imaging, 25 : 146-152.
.2010 .Prostate cancer: Value of multiparametric MR imaging at 3 T for detection-Histopathologic correlation. Radiology, 255 : 89-99.
K. .2017 .Haralick textural features on T2-weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer. J. Magn. Reson. Imaging, 45 : 103-117.
Barrett T,Turkbey B,Choyke PL,Park SY,Jung DC,Oh YT,Tan CH,Wei W,Johnson V,Kundra V .2016 .Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol., 280 : 108.
Weinreb JC,Barentsz JO,Choyke PL,Cornud F,Haider MA,Macura KJ,Margolis D,Schnall MD,Shtern F,Tempany CM,Urol Eur .2016 .PI-RADS prostate imaging - reporting and data system: 2015, Version 2. , 69 : 16-40.
0

Citations

0

Downloads

45

Views